Intelligent Technologies Next-Gen Tech Reshaping Pharma Manufacturing

Pharmaceutical manufacturing is entering a digital era. From AI and digital twins to supercomputers and quantum computing, these technologies are transforming drug discovery, clinical trials, and production. As Siemens’ Andrew Whytock explains, when data is clean, contextualized and usable, and combined with high performance computing, companies can solve more complex problems at speed and the result is better quality, greater flexibility and more reliable right first-time manufacturing.

Smart technology dominates today’s world, be it in the industrial space or in our daily lives – it is everywhere. Even tightly regulated sectors such as pharmaceuticals are adopting next-gen technologies such as Artificial Intelligence (AI), Digital Twins, Supercomputers, and Quantum Computing to enhance production processes, efficiency and even transform the future of drug development.

“At a practical level, these technologies change how decisions are made,” opines Andrew Whytock, Head of Thought Leadership and Market Development, Life Sciences Segment at Siemens. “They help pharma companies act faster and with greater confidence, based on real operational data. Digital twins and simulation allow teams to design, test and refine processes before execution. That reduces risk and shortens time to market. AI builds on this by turning data into predictive insight and supporting real time optimization on the shopfloor, for example by detecting process drift before it affects quality. None of this works without good data. When data is clean, contextualized and usable, and combined with high performance computing, companies can solve more complex problems at speed. The result is better quality, greater flexibility and more reliable right first-time manufacturing.”